﻿<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
	<pubDate>Tue, 30 Dec 2008 14:50:00 EST</pubDate>
	<title>PandemicFlu.gov RSS Feed for News Releases</title>
	<description>Welcome to the PandemicFlu.gov RSS news feed provided by the Department of Health and Human Services. </description>
	<link>http://www.pandemicflu.gov</link>	
	<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://www.hhs.gov/rss/news/hhsnews.xml" type="application/rss+xml" />	
	<category>News</category>
	<language>en-us</language>	 

<item>
  <title>Second Research Team Finds Same Common Achilles’ Heel in Seasonal and Pandemic Flu Viruses</title>
  <description>Researchers at The Scripps Research Institute in La Jolla, California, supported in part by the National Institutes of Health, have identified a common Achilles’ heel in a wide range of seasonal and pandemic influenza A viruses. The study found an infection-fighting protein, or human antibody, that neutralizes various influenza A virus subtypes by attaching to these viruses in the same place. This common attachment site provides a constant region of the flu virus for scientists to target in an effort to develop a so-called universal flu vaccine. Such a vaccine would overcome the annual struggle to make the seasonal flu vaccine match next year’s circulating flu strains and might help blunt emerging pandemic influenza viruses as well.</description>
  <link>http://www3.niaid.nih.gov/news/newsreleases/2009/flu_universal.htm</link>
  <guid>http://www3.niaid.nih.gov/news/newsreleases/2009/flu_universal.htm</guid>
  <pubDate>Fri, 27 Jan 2009 12:00:00 EST</pubDate>
</item>



<item>
  <title>Scientists Identify Proteins That Neutralize Multiple Strains of Seasonal and Pandemic Flu Viruses</title>
  <description>Scientists have identified a small family of lab-made proteins that neutralize a broad range of influenza A viruses, including the H5N1 avian virus, the 1918 pandemic influenza virus and seasonal H1N1 flu viruses. These human monoclonal antibodies, identical infection-fighting proteins derived from the same cell lineage, also were found to protect mice from illness caused by H5N1 and other influenza A viruses. Because large quantities of monoclonal antibodies can be made relatively quickly, after more testing, these influenza-specific monoclonal antibodies potentially could be used in combination with antiviral drugs to prevent or treat the flu during an influenza outbreak or pandemic.</description>
  <link>http://www3.niaid.nih.gov/news/newsreleases/2009/flu_mab.htm</link>
  <guid>http://www3.niaid.nih.gov/news/newsreleases/2009/flu_mab.htm</guid>
  <pubDate>Mon, 23 Jan 2009 12:00:00 EST</pubDate>
</item>



<item>
  <title>HHS Awards $487 Million Contract to Build First U.S. Manufacturing Facility for Cell-Based Influenza Vaccine</title>
  <description>The U.S. Department of Health and Human Services (HHS) today announced a $487 million multiple year contract with Novartis Vaccines and Diagnostics, Inc., to build the first U.S. facility to manufacture cell-based vaccine for seasonal and pandemic flu. Because cell-based influenza vaccine can be made faster and in greater quantities than traditional vaccine, the new facility is expected to increase the U.S. capacity to make pandemic influenza vaccine by at least 25 percent.</description>
  <link>http://www.hhs.gov/news/press/2009pres/01/20090115b.html</link>
  <guid>http://www.hhs.gov/news/press/2009pres/01/20090115b.html</guid>
  <pubDate>Thu, 15 Jan 2009 12:45:00 EST</pubDate>
</item>


<item>
  <title>Federal Assessment Finds Progress, Gaps in State Plans for Pandemic Influenza</title>
  <description>This report summarizes the status of States’ operating plans with respect to preparedness for, response to, and recovery from an influenza pandemic. This report describes the second stage of a two-stage assessment process. Stage One (Stage-1) spanned August 2006 to January 2007. Stage Two (Stage-2) spanned January 2007 to December 2008.</description>
  <link>http://pandemicflu.gov/plan/states/state_assessment.html</link>
  <guid>http://pandemicflu.gov/plan/states/state_assessment.html</guid>
  <pubDate>Thu, 15 Jan 2009 12:45:00 EST</pubDate>
</item>

<item>
  <title>Scientists Isolate Genes that Made 1918 Flu Lethal </title>
  <description>By mixing and matching a contemporary flu virus with the "Spanish flu" — a virus that killed between 20 and 50 million people 90 years ago in history's most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.</description>
  <link>http://www.news.wisc.edu/16103</link>
  <guid>http://www.news.wisc.edu/16103</guid>
  <pubDate>Mon, 29 Nov 2008 12:45:00 EST</pubDate>
</item>


<item>
  <title>HHS Releases Guidance for Use and Stockpiling of Antiviral Drugs for Pandemic Influenza</title>
  <description>Health care workers and emergency services personnel who could have direct contact with individuals who are ill during an influenza pandemic should be protected with antiviral drugs throughout the pandemic, even before these workers are exposed or become ill themselves, according to guidance released today by the U.S. Department of Health and Human Services. </description>
  <link>http://www.hhs.gov/news/press/2008pres/12/20081216a.html</link>
  <guid>http://www.hhs.gov/news/press/2008pres/12/20081216a.html</guid>
  <pubDate>Tue, 16 Dec 2008 14:50:00 EST</pubDate>
</item>


<item>
  <title>FSIS Drafts Avian Flu Risk Assessment for Poultry and Egg Products</title>
  <description>  	
	<p><strong><b>WASHINGTON, Dec. 2, 2008 -</b></strong> The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) is seeking public comments on a draft quantitative food safety risk assessment for highly pathogenic avian influenza (HPAI) virus from consumption of poultry products, shell eggs and egg products. The risk assessment was done in collaboration with the Department of Health and Human Services' Food and Drug Administration (FDA), and USDA's Animal and Plant Health Inspection Service (APHIS).</p>
	<p>The risk assessment was designed to evaluate the relative effectiveness of strategies to reduce or prevent exposure to HPAI virus from consumption of poultry meat, shell eggs and egg products. It may also be used to target risk communication messages, identify and prioritize research needs, and provide a framework for coordinating efforts with stakeholders.</p>
	<p>The risk assessment has been externally peer reviewed, consistent with the requirements in the Office of Management and Budget's "Final Information Quality Bulletin for Peer Review." It has also been reviewed by various government agencies. FSIS intends to review and evaluate all public comments and make modifications to the assessment as appropriate.</p>
	<p>The risk assessment is available on FSIS' Web site at <a  href="http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp">http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp</a>. For further details on the risk assessment, please contact Neal J. Golden, Office of Public Health Science, FSIS, by phone at (202) 690-6419 or by e-mail at <a href="http://www.fsis.usda.gov/contact_us/Email_Form/index.asp?rcpt=Neal.Golden@fsis.usda.gov">Neal.Golden@fsis.usda.gov</a>.</p>
	<p>Comments on the risk assessment must be received by Jan. 31, 2009. Comments can be sent to Docket Clerk, U.S. Department of Agriculture, Food Safety and Inspection Service, Room 2534 South Agriculture Building, 1400 Independence Avenue, SW., Washington, D.C. 20250; e-mailed to <a href="http://www.fsis.usda.gov/contact_us/Email_Form/index.asp?rcpt=fsis.regulationscomments@fsis.usda.gov">fsis.regulationscomments@fsis.usda.gov</a> or submitted through the Federal eRulemaking Portal at <a href="http://www.regulations.gov">www.regulations.gov</a>. All submissions received by mail or electronic mail must reference the Food Safety and Inspection Service and include the docket number FSIS-2007-0001.</p>
  </description>
  <link>http://www.fsis.usda.gov/News_&amp;_Events/NR_120208_01/index.asp</link>
  <guid>http://www.fsis.usda.gov/News_&amp;_Events/NR_120208_01/index.asp</guid>
  <pubDate>Tue, 02 Nov 2008 12:45:00 EST</pubDate>
</item>
	
<item>
  <title>Study of Ancient and Modern Plagues Finds Common Features</title>
  <description>
  	<p>In 430 B.C., a new and deadly disease — its cause remains a mystery — swept into Athens. The walled Greek city-state was teeming with citizens, soldiers and refugees of the war then raging between Athens and Sparta. As streets filled with corpses, social order broke down. Over the next three years, the illness returned twice and Athens lost a third of its population. It lost the war too. The Plague of Athens marked the beginning of the end of the Golden Age of Greece.</p> 
		<p>The Plague of Athens is one of 10 historically notable outbreaks described in an article in The Lancet Infectious Diseases by authors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The phenomenon of widespread, socially disruptive disease outbreaks has a long history prior to HIV/AIDS, severe acute respiratory syndrome (SARS), H5N1 avian influenza and other emerging diseases of the modern era, note the authors.</p>
		<p>"There appear to be common determinants of disease emergence that transcend time, place and human progress," says NIAID Director Anthony S. Fauci, M.D., one of the study authors. For example, international trade and troop movement during wartime played a role in both the emergence of the Plague of Athens as well as in the spread of influenza during the pandemic of 1918-19. Other factors underlying many instances of emergent diseases are poverty, lack of political will, and changes in climate, ecosystems and land use, the authors contend. "A better understanding of these determinants is essential for our preparedness for the next emerging or re-emerging disease that will inevitably confront us," says Dr. Fauci.</p>  	
  </description>
  <link>http://www.nih.gov/news/health/nov2008/niaid-21.htm</link>
  <guid>http://www.nih.gov/news/health/nov2008/niaid-21.htm</guid>
  <pubDate>Thu, 21 Nov 2008 12:45:00 EST</pubDate>
</item>	 

<item>
	      <title>Genetics Provide Evidence for the Movement of Avian Influenza Viruses from Asia to North America via Migratory Birds</title>
	      <description>Wild migratory birds may be more important carriers of avian influenza viruses from continent to continent than previously thought, according to new scientific research that has important implications for highly pathogenic avian influenza virus surveillance in North America. As part of a multi-pronged research effort to understand the role of migratory birds in the transfer of avian influenza viruses between Asia and North America, scientists with the U.S. Geological Survey (USGS), in collaboration with the U.S. Fish and Wildlife Service in Alaska and the University of Tokyo, have found genetic evidence for the movement of Asian forms of avian influenza to Alaska by northern pintail ducks.</description>
	      <link>http://www.usgs.gov/newsroom/article.asp?ID=2044</link>
	      <guid>http://www.usgs.gov/newsroom/article.asp?ID=2044</guid>
	      <pubDate>Fri, 07 Nov 2008 12:45:00 EST</pubDate>
</item>


<item>
	      <title>US Pledges Additional $320 Million in Fight Against Bird Flu</title>
	      <description>Sharm el-Sheikh, Egypt: With the announcement of a new pledge of $320 million for avian and pandemic influenza assistance, U.S. support to international organizations and to more than 90 countries now totals $949 million. Under Secretary of State for Democracy and Global Affairs, Paula Dobriansky, announced the U.S. pledge today at the International Ministerial Conference on Avian and Pandemic Influenza at Sharm el-Sheikh, Egypt.</description>
	      <link>http://www.state.gov/r/pa/prs/ps/2008/oct/111241.htm</link>
	      <guid>http://www.state.gov/r/pa/prs/ps/2008/oct/111241.htm</guid>
	      <pubDate>Mon, 27 Oct 2008 12:45:00 EST</pubDate>
</item>

<item>
	      <title>Early Pandemic Flu Wave May Protect Against Worse One Later</title>
	      <description>New evidence about the worldwide influenza pandemic of 1918-1919 indicates that getting the flu early protected many people against a second deadlier wave, an article co-authored by an NIH epidemiologist concludes.</description>
	      <link>http://www.nih.gov/news/health/oct2008/fic-20.htm</link>
	      <guid>http://www.nih.gov/news/health/oct2008/fic-20.htm</guid>
	      <pubDate>Mon, 20 Oct 2008 13:40:00 EST</pubDate>
</item>

<item>
	      <title>CDC Awards $16.9 Million to Combat Pandemic, Seasonal Influenza</title>
	      <description>The Centers for Disease Control and Prevention (CDC) has awarded a $16.9 million contract to American Type Culture Collection (ATCC) of Manassas, Va. to implement the CDC Influenza Reagent Resource (CDC-IRR), a secure, Web-based system that will improve access to influenza viruses, test kits and other reagents for approved laboratories.</description>
	      <link>http://www.cdc.gov/media/pressrel/2008/r081008.htm </link>
	      <guid>http://www.cdc.gov/media/pressrel/2008/r081008.htm </guid>
	      <pubDate>Thu, 09 Oct 2008 13:40:00 EST</pubDate>
</item>

<item>
	      <title>FDA Clears New CDC Test to Detect Human Influenza</title>
	      <description>The U.S. Food and Drug Administration (FDA) today cleared a new test developed by the U.S. Centers for Disease Control and Prevention (CDC) to diagnose human influenza infections and the highly pathogenic influenza A (H5N1) viruses.</description>
	      <link>http://www.hhs.gov/news/press/2008pres/09/20080930a.html</link>
	      <guid>http://www.hhs.gov/news/press/2008pres/09/20080930a.html</guid>
	      <pubDate>Tue, 30 Sep 2008 11:15:00 EST</pubDate>
</item>

<item>
	      <title>CDC Awards $24 Million for Pandemic Influenza Preparedness Projects</title>
	      <description>The Centers for Disease Control and Prevention (CDC) has awarded $24 million to fund 55 projects in 29 state and local public health departments that could serve as innovative approaches for influenza pandemic preparedness.</description>
	      <link>http://www.cdc.gov/media/pressrel/2008/r080924.htm</link>
	      <guid>http://www.cdc.gov/media/pressrel/2008/r080924.htm</guid>
	      <pubDate>Fri, 19 Jun 2008 11:15:00 EST</pubDate>
</item>


<item>
	      <title>Bacterial Pneumonia Caused Most Deaths in 1918 Influenza Pandemic</title>
	      <description>The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection.</description>
	      <link>http://www.nih.gov/news/health/aug2008/niaid-19.htm</link>
	      <guid>http://www.nih.gov/news/health/aug2008/niaid-19.htm</guid>
	      <pubDate>Fri, 19 Jun 2008 11:15:00 EST</pubDate>
</item>



		</channel>	
</rss>

